Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Lasne

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Thrombosis Research|November 17, 2023
Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort studyFanny Bajolle, Neil Derridj, Joan Bitan, et al.
American Journal of Hematology|October 25, 2011
Concomitant lupus anticoagulant and monoclonal IgMκ antibody in a patient with bleeding tendency: a case report and literature reviewMarie-Alexandra Alyanakian, Hikaru Okada, Christilla Bachelot-Loza, et al.
Thrombosis and Haemostasis|July 15, 2016
Inactivated antithrombins as fondaparinux antidotes: a promising alternative to haemostatic agents as assessed in vitro in a thrombin-generation assayYasmine Bourti, Judicael Fazavana, Marine Armand, et al.
Thrombosis and Haemostasis|December 8, 2004
Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole bloodMahnouch Khairy, Dominique Lasne, Aymeric Amelot, et al.
British Journal of Haematology|February 1, 2011
Thrombin generation in patients with acquired haemophilia and clinical bleeding riskArnaud Millet, Julie Graveleau, Pierre Gueret, et al.
Annales De Biologie Clinique|April 28, 2018
[Guidelines for certification of International Normalized Ratio (INR) for vitamin K antagonists monitoring according to the EN ISO 22870 standards]Marie Brionne-François, Anne Bauters, Christine Mouton, et al.
British Journal of Haematology|July 16, 2010
Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disordersDominique Lasne, Geneviève Baujat, Tristan Mirault, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 26, 2023
The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practicesNûn K Bentounes, Dominique Lasne, Capucine Habay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2024
Emicizumab and asparaginase, A first experience to shareLaurie Goubeau, Cécile Bally, Delphine Borgel, et al.
Platelets|November 18, 2024
Light transmission aggregometry for platelet function testing: position paper on current recommendations and French proposals for accreditationAlain Stépanian, Florence Fischer, Claire Flaujac, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Thrombosis Research|November 17, 2023
Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort studyFanny Bajolle, Neil Derridj, Joan Bitan, et al.
American Journal of Hematology|October 25, 2011
Concomitant lupus anticoagulant and monoclonal IgMκ antibody in a patient with bleeding tendency: a case report and literature reviewMarie-Alexandra Alyanakian, Hikaru Okada, Christilla Bachelot-Loza, et al.
Thrombosis and Haemostasis|July 15, 2016
Inactivated antithrombins as fondaparinux antidotes: a promising alternative to haemostatic agents as assessed in vitro in a thrombin-generation assayYasmine Bourti, Judicael Fazavana, Marine Armand, et al.
Thrombosis and Haemostasis|December 8, 2004
Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole bloodMahnouch Khairy, Dominique Lasne, Aymeric Amelot, et al.
British Journal of Haematology|February 1, 2011
Thrombin generation in patients with acquired haemophilia and clinical bleeding riskArnaud Millet, Julie Graveleau, Pierre Gueret, et al.
Annales De Biologie Clinique|April 28, 2018
[Guidelines for certification of International Normalized Ratio (INR) for vitamin K antagonists monitoring according to the EN ISO 22870 standards]Marie Brionne-François, Anne Bauters, Christine Mouton, et al.
British Journal of Haematology|July 16, 2010
Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disordersDominique Lasne, Geneviève Baujat, Tristan Mirault, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 26, 2023
The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practicesNûn K Bentounes, Dominique Lasne, Capucine Habay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2024
Emicizumab and asparaginase, A first experience to shareLaurie Goubeau, Cécile Bally, Delphine Borgel, et al.
Platelets|November 18, 2024
Light transmission aggregometry for platelet function testing: position paper on current recommendations and French proposals for accreditationAlain Stépanian, Florence Fischer, Claire Flaujac, et al.
Pageof 10